Skip to main content

High impact publications

Recent publications with one or several authors from Department of Medicine, Huddinge in high impact journals.

Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation.
Emgård J, Kammoun H, García-Cassani B, Chesné J, Parigi S, Jacob J, et al
Immunity 2018 01;48(1):120-132.e8

A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone V, Hankaniemi M, Svedin E, Sioofy-Khojine A, Oikarinen S, Hyöty H, et al
Diabetologia 2018 02;61(2):476-481

Gingival Tissue Inflammation Promotes Increased Matrix Metalloproteinase-12 Production by CD200R Monocyte-Derived Cells in Periodontitis.
Björnfot Holmström S, Clark R, Zwicker S, Bureik D, Kvedaraite E, Bernasconi E, et al
J. Immunol. 2017 12;199(12):4023-4035

Carrelha J, Meng Y, Kettyle LM, Luis TC, Norfo R, Alcolea V, Grasso F, Gambardella A, Grover A, Högstrand K, Lord AM, Sanjuan-Pla A, Woll PS, Nerlov C, Jacobsen SEW
Nature (2018) Online 3 January. Letter.

Abstract in Nature

Dias J, Leeansyah E, Sandberg J

Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.
Dias J, Leeansyah E, Sandberg J
Proc. Natl. Acad. Sci. U.S.A. 2017 07;114(27):E5434-E5443

Sandberg J, Norrby-Teglund A, Leeansyah E

 Bacterial deception of MAIT cells in a cloud of superantigen and cytokines.
Sandberg J, Norrby-Teglund A, Leeansyah E
PLoS Biol. 2017 Jul;15(7):e2003167

Dias J, Sobkowiak M, Sandberg J, Leeansyah E, Center for Infectious Medicine

Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity.
Dias J, Sobkowiak M, Sandberg J, Leeansyah E
J. Leukoc. Biol. 2016 07;100(1):233-40

Malin Flodström Tullberg, Center for Infectious Medicine

Enteroviral proteases: structure, host interactions and pathogenicity.
Laitinen O, Svedin E, Kapell S, Nurminen A, Hytönen V, Flodström-Tullberg M
Rev. Med. Virol. 2016 07;26(4):251-67

Malin Flodström Tullberg, Center for Infectious Medicine

28000722

Rickard Sandberg, Integrated Cardio Metabolic Centre (ICMC), CMB

27667667

Soo Aleman, Enheten för inflammation, gastroenterologi och reumatologi

27282709

Johan K. Sandberg, Edwin Leeansyah, Center for Infectious Medicine

27481843

Johan K. Sandberg, Edwin Leeansyah, Center for Infectious Medicine

27049062

Mikael Rydén, Peter Arner, Unit for Endocrinology and Diabetes

The Adipose Transcriptional Response to Insulin Is Determined by Obesity, Not Insulin Sensitivity

Anders Sönnerborg, Unit for Infection and Dermatology:

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CA, Schmit JC, Wensing AM; SPREAD Program.

Clin Infect Dis. 2016 Mar 1;62(5):655-63. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

Jenny Mjösberg, Center for Infectious Medicine:

26878113.

.

Anders Sönnerborg, Amanda Häggblom, Enheten för infektionssjukdomar och hud:

Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.
Neogi U, Häggblom A, Singh K, Rogers L, Rao S, Amogne W, et al
J. Antimicrob. Chemother. 2016 Feb;71(2):367-71.

.

Anders Sönnerborg, Amanda Häggblom, Enheten för infektionssjukdomar och hud:

Häggblom A, Svedhem V, Singh K, Sönnerborg A, Neogi U. Viral failure in HIV-1 subtype C infected patients receiving anti-retroviral therapy in a national health care setting: A real-life prospective cohort study. Lancet HIV 2016.

Anders Sönnerborg, Enheten för infektionssjukdomar och hud:

Noguera-Julian M, Rocafort M, Guillén Y, Rivera J, Casadellà M, Nowak P, Hildebrand F, Zeller G, Parera M, Bellido R, Rodríguez C, Carrillo J, Mothe B, Coll J, Bravo I, Estany C, Herrero C, Saz J, Sirera G, Torrela A, Navarro J, Crespo M, Brander C, Negredo E, Blanco J, Guarner F, Luz Calle M, Bork P, Sönnerborg A, Clotet B, Paredes R. Gut microbiota linked to sexual practice and HIV infection. eBiomedicine 2016

Anders Sönnerborg, Enheten för infektionssjukdomar och hud:

Gupta R Sönnerborg A for the TenoRes collaboration. Global epidemiology of drug resistance following failure of WHO recommended first line regimens for adult HIV-1 infection – a multicenter retrospective cohort study. Lancet Infectious Diseases 2016, http://dx.doi.org/10.1016/S1473-3099(15)00536

Per Ljungman, Unit of Hematology:

Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.
Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V, et al
Clin. Infect. Dis. 2015 Aug;61(3):313-23

Per Ljungman, Unit of Hematology:

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.
Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, et al
Blood 2015 Oct;126(16):1885-92; quiz 1970

Hareth Nahi, Center for Hematology and Regenerative Medicine:

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.
Lokhorst H, Plesner T, Laubach J, Nahi H, Gimsing P, Hansson M, et al
N. Engl. J. Med. 2015 Sep;373(13):1207-19

Mattias Svensson, Center for Infectious Medicine:

26160381.

.

Susanna Brighenti och Jagadees Rao Muvva, Center for Infectious Medicine:

26218841.

.

Mikael Rydén, Peter Arner, Daniel P Andersson, Erik Arner, Yvonne Widlund, Niklas Mejhert, Unit of Endocrinology with the Lipid laboratory:

 26190649

Hannes Hagström, Per Stål och Rolf Hultcrantz, Unit of Gastroenterology and Rheumatology:

 Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, et al
Hepatology 2015 May;61(5):1547-54

Dina Melki and Tomas Jernberg, Unit of Heart and Lung Diseases:

Implications of introducing high-sensitivity cardiac troponin T into clinical practice
Melki D, Lugnegård J, Alfredsson J, Lind S, Eggers KM, Lindahl B, Jernberg T.
J Am Coll Cardiology (2015) Online 20 April. Original investigation.

Hans-Gustaf Ljunggren and Yenan Bryceson, Center for Infectious Medicine:

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function
Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SCC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg K-J, Ljunggren H-G, Miller JS, Bryceson YT.
Immunity (2015) Online 17 March. Article.

Karolina Szummer, Unit of Heart and Lung Diseases:

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
Szummer K, Oldgren J, Lindhagen L, Carrero J, Evans M, Spaak J, et al
JAMA 2015 Feb;313(7):707-16

Professor Johan Sandberg, Center for Infectious Medicine:

HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.
Eller M, Opollo M, Liu M, Redd A, Eller L, Kityo C, et al
J. Infect. Dis. 2015 May;211(10):1574-84

Professor Anders Sönnerborg, Unit of Infectious Diseases and Dermatology:

Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals.
Stenkvist J, Nyström J, Falconer K, Sönnerborg A, Weiland O
J. Hepatol. 2014 Oct;61(4):957-61

Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients.
Neogi U, Rao S, Bontell I, Verheyen J, Rao V, Gore S, et al
AIDS 2014 Sep;28(15):2319-22

Professor Ola Weiland, Unit of Infectious Diseases and Dermatology:

ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
Andreone P, Colombo M, Enejosa J, Koksal I, Ferenci P, Maieron A, et al
Gastroenterology 2014 Aug;147(2):359-365.e1

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study.
Younossi Z, Stepanova M, Zeuzem S, Dusheiko G, Esteban R, Hezode C, et al
J. Hepatol. 2014 Aug;61(2):228-34